Cargando…
Temporary Efficacy of Pyrimethamine in Juvenile-Onset Tay-Sachs Disease Caused by 2 Unreported HEXA Mutations in the Indian Population
BACKGROUND: Juvenile Tay-Sachs disease is rarer than other forms of Tay-Sachs disease and is usually seen in children between the age of 2 and 10 years. Pyrimethamine as a pharmacological chaperone was used to increase β-hexosaminidase A activity in this patient. PATIENT: We describe a patient with...
Autores principales: | Udwadia-Hegde, Anaita, Hajirnis, Omkar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417282/ https://www.ncbi.nlm.nih.gov/pubmed/28503624 http://dx.doi.org/10.1177/2329048X16687887 |
Ejemplares similares
-
Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease
por: Sheth, Jayesh, et al.
Publicado: (2014) -
Neurodegeneration with Progressive Dystonia: Juvenile-Onset Tay–Sachs Disease
por: Kaur, Jasmine, et al.
Publicado: (2022) -
Enfermedad de Tay Sachs
por: Cibrián Cruz, José Alberto
Publicado: (1996) -
Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot study
por: Osher, Etty, et al.
Publicado: (2015) -
Identification of Novel Mutations in HEXA Gene in Children Affected with Tay Sachs Disease from India
por: Mistri, Mehul, et al.
Publicado: (2012)